Application 065377
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXYCYCLINE | DOXYCYCLINE | TABLET;ORAL | EQ 50MG BASE | No | No |
| 002 | DOXYCYCLINE | DOXYCYCLINE | TABLET;ORAL | EQ 75MG BASE | No | No |
| 003 | DOXYCYCLINE | DOXYCYCLINE | TABLET;ORAL | EQ 100MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-6021 | Doxycycline | Doxycycline | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-6022 | Doxycycline | Doxycycline | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-6023 | Doxycycline | Doxycycline | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-6023 | Doxycycline | Doxycycline | Mylan Pharmaceuticals Inc. | ANDA | Current |